Lessons from the first generation of cell and gene oncology trialsAdvances in cell and gene science are paving the way for transformative cancer treatments, but there are still Share XLessons from the first generation of cell and gene oncology trialshttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/lessons-from-the-first-generation-of-cell-gene-oncology-trials/
Nine for 2019: how did we do on our predictions, and what does this mean for 2020?Year-ends prompt reflection, both on what’s happened in the last 12 months and on the year ahead. At Share XNine for 2019: how did we do on our predictions, and what does this mean for 2020?https://pharmaphorum.com/views-and-analysis/nine-for-2019-2020/
Nine for 2019: Opportunities for pharmaIn the last Nine for 2019 article, we reflected on the major challenges that are shaping the pharmaceutical Share XNine for 2019: Opportunities for pharmahttps://pharmaphorum.com/views-and-analysis/nine-for-2019-opportunities-for-pharma/
